Zhejiang Starry PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 1/6
Zhejiang Starry PharmaceuticalLtd is a dividend paying company with a current yield of 0.95%.
Key information
1.0%
Dividend yield
-20.0%
Buyback Yield
Total Shareholder Yield | -19.1% |
Future Dividend Yield | 1.0% |
Dividend Growth | 2.5% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.100 |
Payout ratio | 147% |
Recent dividend and buyback updates
No updates
Recent updates
There's No Escaping Zhejiang Starry Pharmaceutical Co.,Ltd.'s (SHSE:603520) Muted Revenues
Sep 30Shareholders Can Be Confident That Zhejiang Starry PharmaceuticalLtd's (SHSE:603520) Earnings Are High Quality
May 06Market Might Still Lack Some Conviction On Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) Even After 31% Share Price Boost
Mar 12Is Zhejiang Starry PharmaceuticalLtd (SHSE:603520) Using Too Much Debt?
Feb 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603520 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603520 has only been paying a dividend for 8 years, and since then payments have fallen.
Dividend Yield vs Market
Zhejiang Starry PharmaceuticalLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603520) | 1.0% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (603520) (up to 3 years) | 1.0% |
Notable Dividend: 603520's dividend (0.95%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 603520's dividend (0.95%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (147.1%), 603520's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 603520 is paying a dividend but the company has no free cash flows.